Market Cap 3.03M
Revenue (ttm) 0.00
Net Income (ttm) -24.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 112,759
Avg Vol 132,326
Day's Range N/A - N/A
Shares Out 5.09M
Stochastic %K 100%
Beta 1.36
Analysts Hold
Price Target $50.00

Latest News on MTNB

Matinas BioPharma Receives NYSE Noncompliance Notice

Jan 10, 2025, 5:15 PM EST - 3 months ago

Matinas BioPharma Receives NYSE Noncompliance Notice


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 1 year ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS AVTX TPST